IN-VITRO EFFICACY OF PIPERACILLIN/SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN/TAZOBACTAM AND CEFOPERAZONE/SULBACTAM. (2026). Frontier in Medical and Health Research, 4(3), 4971-4977. https://fmhr.net/index.php/fmhr/article/view/3904